Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3266
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00941928 | Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) | ||
| NCT00500734 | Cardiomyopathy Tissue Bank in a Cancer Population | ||
| NCT00510367 | Primary Breast Cancer Occurring Concomitant With Pregnancy | ||
| NCT06412198 | A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations | ||
| NCT01751438 | Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) | ||
| NCT05023967 | Metformin and Nightly Fasting in Women With Early Breast Cancer | ||
| NCT02959463 | Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma | ||
| NCT00791271 | Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion | ||
| NCT06004063 | Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study | ||
| NCT00003693 | Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia | ||
| NCT04752163 | DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia | ||
| NCT00671606 | Hysteroscopic Lymphatic Mapping for Endometrial Cancer | ||
| NCT07140757 | Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers | ||
| NCT01262664 | A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity | ||
| NCT00507572 | Collection of Outcomes Data for Pregnant Patients With Cancer | ||
| NCT06308419 | A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions | ||
| NCT03077841 | Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer | ||
| NCT00002831 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia | ||
| NCT01927744 | Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection | ||
| NCT03519451 | Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment | ||
| NCT00503919 | Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device | ||
| NCT01099202 | Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy | ||
| NCT05842031 | Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer | ||
| NCT01844557 | Testing Accountability in Patient Adherence | ||
| NCT00800839 | Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide | ||
| NCT00675467 | Palliative Care and Symptom Management for the Pediatric Oncology Patient | ||
| NCT00004136 | Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer | ||
| NCT00083772 | Use of Nesiritide in the Management of Acute Diastolic Heart Failure | ||
| NCT01794702 | Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia | ||
| NCT01738139 | Ipilimumab and Imatinib Mesylate in Advanced Cancer | ||
| NCT01319981 | Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia | ||
| NCT05035836 | A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) | ||
| NCT06144151 | A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity | ||
| NCT04265430 | Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors | ||
| NCT01365169 | Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" | ||
| NCT04054154 | An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided Biopsy | ||
| NCT05041153 | Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma | ||
| NCT03111069 | Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children | ||
| NCT02930902 | Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery | ||
| NCT06885203 | Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI) | ||
| NCT02877303 | Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia | ||
| NCT00500942 | Pain Quantification and Pain Management in Interventional Radiology (IR) | ||
| NCT00354705 | Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients | ||
| NCT03048266 | Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients | ||
| NCT01492673 | Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma | ||
| NCT05776979 | Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients | ||
| NCT01003054 | Autologous Transplantation for Chronic Myelogenous Leukemia | ||
| NCT01178307 | Symptom Inventory for Gastrointestinal Stromal Tumors | ||
| NCT00506779 | Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma | ||
| NCT03128879 | Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL |
